NCT02538822

Brief Summary

Aneurysms of the thoracic ascending aorta are a serious pathology which may threatens life by rupture or dissection. Their incidence is estimated at 10.4 per 100,000 people. At present, the only parameter for assessing the risk of complication is the maximum diameter of the aneurysm. The only way to avoid a complication is a surgical replacement of the aneurysmal aorta by a prosthetic tube. This procedure is performed by sternotomy and with extracorporeal circulation and its death rate ranges between 3% and 5%. Surgical repair is indicated when the diameter of the aneurysm exceeds 5.5 cm for degenerative atheromatous aneurysms or 5 cm in a patient with genetic disorder of connective tissue (Marfan disease or Ehlers-Danlos syndrome). However, there are aneurysms with diameter greater than the surgical threshold which remain stable. Conversely, complications have been described for aneurysms less than 4.5 cm in diameter. The criterion of diameter appears therefore as inadequate to assess the risk of complication of an aneurysm of the ascending aorta.Multiple methods have been described in the literature. One of them relies on in vitro mechanical testing on healthy or aneurysmal tissue. Another method is the vivo analysis from imaging (CT, MRI or ultrasound). So far, no algorithm is robust enough for predicting the risk of complication better than the universally used criterion of diameter. The pathophysiology of these aneurysms has also been explored from histological studies. The investigators know that the microstructure of the aortic wall of an aneurysm is deteriorated with a degradation of elastin fibers and collagen that determine to a large extent its biomechanical behavior. Histological analysis appears inseparable from biomechanical analysis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 6, 2014

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 31, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 2, 2015

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 16, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 16, 2018

Completed
Last Updated

May 24, 2023

Status Verified

January 1, 2020

Enrollment Period

3.9 years

First QC Date

August 31, 2015

Last Update Submit

May 23, 2023

Conditions

Keywords

aortic aneurysmthoracic ascending aortaATAdynamic imagingmechanical testing

Outcome Measures

Primary Outcomes (1)

  • Correlation between index of risk of the rupture and in vivo physiological elasticity.

    The index of risk of rupture is a composite measure : * an in vivo study of biomechanical behavior of aneurysmal aorta from preoperative dynamic imaging (dynamic CT-scan and 4D-MRI). It will determine the maximum stress borne by the aortic wall and its physiological elasticity. * an in vitro study with mechanical inflation testing of aneurysmal aortic tissue harvested during surgery. These tests will be conducted up to rupture and will bring results on the elasticity of the aortic wall of the aneurysm and its mode of failure. * finally, a histological analysis, with measurement of elastin and collagen content. The physiological elasticity is measured from MRI

    day 1

Study Arms (1)

thoracic ascending aorta (ATA)

EXPERIMENTAL

the risk of rupture of thoracic ascending aorta (ATA) is assessed fom the dynamic imaging and mechanical testing

Device: dynamic imagingDevice: mechanical testing

Interventions

In vivo study of biomechanical behavior of ATA from preoperative dynamic imaging : dynamic CT-scan and 4D-magnetic resonance imaging (MRI)

thoracic ascending aorta (ATA)

In vitro study of with mechanical inflation testing of ATA tissue harvested during surgery.

thoracic ascending aorta (ATA)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diameter of ATA exceeds 5.5 cm
  • Diameter of ATA exceeds 5 cm in a patient with genetic disorder of connective tissue (Marfan disease or Ehlers-Danlos syndrome)
  • Diameter of ATA exceeds 5 cm in a patient with aortic valvulopathy
  • Written consent

You may not qualify if:

  • Contra-indication to MRI
  • Chronic insufficiency kidney

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Saint-Etienne

Saint-Etienne, 42055, France

Location

MeSH Terms

Conditions

Aortic Aneurysm, ThoracicAortic Aneurysm

Interventions

Mechanical Tests

Condition Hierarchy (Ancestors)

AneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Intervention Hierarchy (Ancestors)

Materials TestingInvestigative Techniques

Study Officials

  • Salvatore CAMPISI, MD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2015

First Posted

September 2, 2015

Study Start

October 6, 2014

Primary Completion

September 16, 2018

Study Completion

September 16, 2018

Last Updated

May 24, 2023

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations